Skip to content

Role of Homoeopathic medicines in the cases of male androgenetic alopecia

Role of anti miasmatic medicines in the cases of male androgenetic alopecia in age group of 15-30 years - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080961
Enrollment
40
Registered
2025-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Antimiasmatic medicine: Potency Various such as Centicimal Decimal 50 millesimal etc Doses as per need of cases Medicine will be Dispended as per potency Frequency as per Need of cases

Sponsors

DR DIPALBEN HARSHADRAY RAVAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Already diagnosed case of androgenetic alopecia up to stage III baldness of Norwood- Hamilton classification Patients who gives consent Patients who are able and understand to fill HSS29 score

Exclusion criteria

Exclusion criteria: Patients with scalp injury any scalp surgery Patients with past and present history of scalp lichen planus history of chronic cutaneous lupus erythematosus involving scalp and scalp eczema scalp psoriasis and inflammatory tinea capitis Patients with uncontrolled thyroid disease Patients who have taken hormone replacement therapy within past 6 months Patients with existing malignancy and history of malignancy with in the past 5 years

Design outcomes

Secondary

MeasureTime frame
Assessed by Hair Specific Skindex 29 ScoreTimepoint: assessed at baseline and end of treatment

Primary

MeasureTime frame
Androgenetic alopecia will be assessed with Trichoscopic examinationTimepoint: Androgenetic alopecia will be assessed at baseline and end of treatment

Countries

India

Contacts

Public ContactDR DIPALBEN HARSHADRAY RAVAL

Smt A J Savla Homoeopathic Medical College and Research Institute

dranandjvb@gmail.com9429545666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026